Business ❯ Healthcare

Corporate Strategy

Mergers and Acquisitions Operational Efficiency Product Development Amazon Health Services Inorganic Growth Leadership Changes Competition Sales Management Value Creation Activism Spin-offs Financial Performance String of Pearls Strategy

Johnson & Johnson Beats Q2 Estimates and Lifts Full‑Year Outlook

Strong drug sales powered the quarter with MedTech shortfalls and biosimilar losses keeping longer‑term risks in view.

Biote and Harvard Bioscience Set Cautious 2026 Outlooks After Rebuild Year

Moderna Raises 2025 Revenue Forecast, Deepens Cost Cuts as Shares Jump

J&J to Spin Off $9 Billion Orthopedics Unit as DePuy Synthes Within Two Years

KindlyMD Sets $5 Billion ATM Shelf to Expand Bitcoin Treasury